Conéctate
E-mail
Contraseña
Mostrar la contraseña
Recuerde
¿Olvidó su contraseña?
Inscríbase gratis
Regístrate
Regístrate
Configuraciones
Configuraciones
Cotizaciones dinámicas 
OFFON

IDERA PHARMACEUTICALS, INC.

(IDRA)
ResumenCotizacionesGráficosNoticiasRatingsAgendaEmpresaFinanzasConsensoRevisionesDerivados 
ResumenTodasRecomendaciones analistasOtros idiomasComunicadosPubls. oficialesNoticias del sector
Noticias en otros idiomas sobre IDERA PHARMACEUTICALS, INC.
01/12IDERA PHARMACEUTICALS, INC. : Notice of Delisting or Failure to Satisfy a Continued Listin..
08/11IDERA : Q3 Earnings Snapshot
08/11Idera Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Corpora..
08/11Idera Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Corpora..
08/11IDERA PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Conditio..
08/11Idera Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Mon..
09/08IDERA : Q2 Earnings Snapshot
09/08IDERA PHARMACEUTICALS : Reports Second Quarter 2021 Financial Results and Provides Corpora..
09/08IDERA PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and Re..
09/08Idera Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter Ended June ..
25/06IDERA PHARMACEUTICALS, INC.(NASDAQCM : IDRA) added to Russell 3000E Value Index
25/06IDERA PHARMACEUTICALS, INC.(NASDAQCM : IDRA) dropped from Russell Microcap Growth Index
25/06IDERA PHARMACEUTICALS, INC.(NASDAQCM : IDRA) added to Russell Microcap Value Index
25/06IDERA PHARMACEUTICALS, INC.(NASDAQCM : IDRA) dropped from Russell 3000E Growth Index
22/06IDERA PHARMACEUTICALS : Thinking about buying stock in Biocept, Histogen, Idera Pharmaceut..
10/06IDERA PHARMACEUTICALS, INC. : Submission of Matters to a Vote of Security Holders (form 8-..
10/06Idera Pharmaceuticals, Inc. Ratifies the Selection of Ernst & Young LLP as the Independ..
03/06INSIDER TRENDS : 90-Day Buying Trend Extended with Insider Purchase of Idera Pharmaceutica..
18/05IDERA PHARMACEUTICALS : Announces Corporate Updates (Form 8-K)
18/05IDERA PHARMACEUTICALS : Cancels Advanced Melanoma Treatment Study, Chief Medical Officer t..
18/05IDERA PHARMACEUTICALS, INC. : Change in Directors or Principal Officers, Other Events, Fin..
18/05Elizabeth Tarka to Cease as Senior Vice President, Chief Medical Officer of Idera Pharm..
18/05Idera Pharmaceuticals, Inc. Announces the Cessation of Dr. Elizabeth Tarka as Senior Vi..
18/05Idera Pharmaceuticals Announces Corporate Updates
18/05Idera Pharmaceuticals Announces Corporate Updates
29/04Idera Pharmaceuticals, Inc. Announces Board Changes
29/04Idera Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March ..
19/03AFTER HOURS WATCH LIST SCORECARD : Knsa, mp, idra
19/03SECTOR UPDATE : Health Care Stocks End Near Friday Session Highs
19/03SECTOR UPDATE : Health Care Stocks Hanging On For Friday Gain
19/03MIDDAY REPORT : Wall Street Mixed Midday, Banks Slip on End to Loose Capital Rule
19/03Wall Street Set for Mixed Open as Bond Yields Move Off Lows After Fed Says it Won't Ext..
18/03MT NEWSWIRES AFTER HOURS WATCH LIST : Knsa, mp, idra
18/03IDERA PHARMACEUTICALS : Resumes Trade - Cratering More Than 60% After Melanoma Treatment F..
18/03IDERA PHARMACEUTICALS : Says Melanoma Treatment Trial Did Not Meet Primary Goal
18/03IDERA PHARMACEUTICALS TRIAL FOR ADVA : 45 pm ET
18/03IDERA PHARMACEUTICALS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
18/03Idera Pharmaceuticals Announces Results From ILLUMINATE-301 Trial of Tilsotolimod + Ipi..
18/03Idera Pharmaceuticals, Inc. Announces Results From ILLUMINATE-301 Trial of Tilsotolimod..
01/03IDERA : 4Q Earnings Snapshot
01/03Idera Pharmaceuticals, Inc. Reports Earnings Results for the Fourth Quarter Ended Decem..
01/03Idera Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and P..
01/03IDERA PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and Re..
13/01IDERA PHARMACEUTICALS, INC. : Regulation FD Disclosure, Financial Statements and Exhibits ..
11/01IDERA PHARMACEUTICALS, INC. : Regulation FD Disclosure, Financial Statements and Exhibits ..
11/01Idera Pharmaceuticals to Present at Upcoming Conferences
05/01IDERA PHARMACEUTICALS, INC. : Change in Directors or Principal Officers, Financial Stateme..
05/01Idera Pharmaceuticals, Inc. Announces Resignation of R. Clayton Fletcher as Senior Vice..
2020INSIDER TRENDS : Insider Buying Added to with Purchase of Idera Pharmaceuticals Shares
2020IDERA PHARMACEUTICALS, INC. : Entry into a Material Definitive Agreement, Unregistered Sal..
2020Idera Pharmaceuticals Announces $5.0 Million in Further Proceeds from Private Placement..
2020Idera Pharmaceuticals, Inc. announced that it has received $9.999998 million in funding..
2020IDERA PHARMACEUTICALS : Announces Dan Soland to Join as Chief Operating Officer
2020IDERA PHARMACEUTICALS : Names Daniel Soland as COO
2020IDERA PHARMACEUTICALS : Announces Dan Soland to Join as Chief Operating Officer
2020Idera Pharmaceuticals Announces Dan Soland to Join as Chief Operating Officer
2020Idera Pharmaceuticals, Inc. Announces Board Changes
2020IDERA PHARMACEUTICALS, INC. : Change in Directors or Principal Officers, Financial Stateme..
2020IDERA PHARMACEUTICALS : Reports Third Quarter Financial Results and Provides Corporate Upd..
2020IDERA : 3Q Earnings Snapshot
2020IDERA PHARMACEUTICALS, INC. : Results of Operations and Financial Condition (form 8-K)
2020Idera Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter Ended Septem..
2020IDERA PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and Re..
2020IDERA PHARMACEUTICALS : Reports Third Quarter Financial Results and Provides Corporate Upd..
2020Idera Pharmaceuticals Reports Third Quarter Financial Results and Provides Corporate Up..
2020IDERA PHARMACEUTICALS : Announces New U.S. Patent Coverage for Tilsotolimod through Septem..
2020IDERA PHARMACEUTICALS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
2020IDERA PHARMACEUTICALS : Announces New U.S. Patent Coverage for Tilsotolimod Through Septem..
2020Idera Pharmaceuticals Announces New U.S. Patent Coverage for Tilsotolimod Through Septe..
2020IDERA PHARMACEUTICALS : to Present Tilsotolimod Data at ESMO Virtual Congress 2020
2020Idera Pharmaceuticals to Present Tilsotolimod Data at ESMO Virtual Congress 2020
2020IDERA PHARMACEUTICALS, INC. : Entry into a Material Definitive Agreement, Other Events, Fi..
2020IDERA PHARMACEUTICALS : August 2020 Corporate Overview
2020IDERA PHARMACEUTICALS : August 2020 Corporate Overview 4.6 MB
2020IDERA : 2Q Earnings Snapshot
1  2  3Siguiente
Próximo evento sobre IDERA PHARMACEUTICALS, INC.
Próximos eventos en el sector